News

Clinical Trials Arena1h
Enrolment concludes in Beacon Therapeutics’ trial of laru-zova for XLRP
Beacon Therapeutics has completed the enrolment in its randomised, registrational Phase II/III VISTA trial of laru-zova.
Clinical Trials Arena3h
Arrowhead doses first patient in Phase III trial of zodasiran for HoFH treatment
Arrowhead has dosed the first participant in the Phase III YOSEMITE trial of zodasiran, under development for treating HoFH.
Clinical Trials Arena21h
UroGen concludes enrolment in Phase III trial of UGN-103 for bladder cancer
UroGen Pharma has completed the enrolment of subjects in its Phase III UTOPIA trial, which is evaluating UGN-103 for intravesical solution.